• Теги
    • избранные теги
    • Компании867
      • Показать ещё
      Международные организации9
      Разное306
      • Показать ещё
      Страны / Регионы164
      • Показать ещё
      Люди99
      • Показать ещё
      Формат10
      Показатели18
      • Показать ещё
      Издания30
      • Показать ещё
      Сферы1
27 июля, 19:14

McKesson (MCK) Misses Earnings Estimates in Q1, Raises View

McKesson's (MCK) performance was muted in the first quarter owing to branded to generic conversions and competition in its pharmacy business.

27 июля, 15:48

McKesson (MCK) Misses on Earnings and Sales in Q1

McKesson???s adjusted earnings of $2.46 per share missed the Zacks Consensus Estimate of $2.81 and decreased from $3.15 in the year-ago quarter.

26 июля, 16:51

Med-Products' Q2 Earnings Roster for Jul 27: ALGN, BSX & More

The ongoing conflict related to healthcare policy implementation in the U.S. might get reflected in the Q2 results of these companies.

Выбор редакции
26 июля, 04:03

CEO's pay is under fire amid opioid epidemic

McKesson holds its annual shareholder meeting on Wednesday. On the agenda: concerns about CEO John Hammergren's compensation.

Выбор редакции
26 июля, 04:03

CEO's pay is under fire amid opioid epidemic

McKesson CEO John Hammergren has earned $692 million in the past 10 years. The Teamsters think that's too much.

21 июля, 15:54

McKesson (MCK) Q1 Earnings: Stock Likely to Beat Estimates?

McKesson's (MCK) strategic acquisitions and promising guidance raise optimism for the first quarter of fiscal 2018.

20 июля, 16:07

Quest Diagnostics Closes Deal to Acquire 2 Labs in Texas

Quest Diagnostics (DGX) acquires Med Fusion and Clear Point lab businesses to grow in oncology space.

19 июля, 23:43

Suspensions for College Students Who Thwarted Free Speech

Claremont McKenna punished multiple campus activists who shut down an event featuring a pro-police speaker—but were those punishments justified?

Выбор редакции
15 июля, 07:11

Idaho news station apologizes for using photo of Black Lives Matter activist DeRay McKesson in unrelated bank robbery story

An local CBS news affiliate in Idaho has issued a public apology to Black Lives Matter activist...

13 июля, 16:17

McKesson (MCK) Poised on Improving Generic and Brand Market

On Jul 12, we issued an updated research report on San Francisco, CA-based McKesson Corporation (MCK).

13 июля, 01:02

Top Analyst Reports for Microsoft, Wal-Mart & Home Depot

Top Analyst Reports for Microsoft, Wal-Mart & Home Depot

11 июля, 16:31

AmerisourceBergen's PharMEDium Slows Down, Competition Rife

On Jul 10, we issued an updated research report on Chesterbrook, PA-based AmerisourceBergen Corporation (ABC).

10 июля, 17:50

An Ill-Advised Lawsuit Against Black Lives Matter Activists

A Baton Rouge police officer blames the movement and its leaders for a killer’s acts.

Выбор редакции
08 июля, 17:39

CLIMATE OF HATE: Injured Baton Rouge police officer sues Black Lives Matter, Deray McKesson. “Frid…

CLIMATE OF HATE: Injured Baton Rouge police officer sues Black Lives Matter, Deray McKesson. “Friday’s lawsuit claims Mckesson was ‘in charge of’ a July 9 protest that ‘turned into a riot.’ Mckesson ‘did nothing to calm the crowd and, instead, he incited the violence’ on behalf of Black Lives Matter, the suit alleges.” It’s hard […]

05 июля, 16:38

Apple's Tim Cook earns $145M in 2016, Tops S&P 500 CEOs

Apple Inc.'s (AAPL) Chief Executive Officer (CEO) Tim Cook has been declared the highest-paid CEO in the U.S., per a Bloomberg's report of take-home pay for the top 25 S&P 500 CEOs.

22 июня, 16:46

Should Value Investors Consider McKesson (MCK) Stock?

Value investing is easily one of the most popular ways to find great stocks in any market environment.

22 июня, 00:18

U.S. Supreme Court Ruling Threatens Massive Talc Litigation Against J&J

function onPlayerReadyVidible(e){'undefined'!=typeof HPTrack&&HPTrack.Vid.Vidible_track(e)}!function(e,i){if(e.vdb_Player){if('object'==typeof commercial_video){var a='',o='m.fwsitesection='+commercial_video.site_and_category;if(a+=o,commercial_video['package']){var c='&m.fwkeyvalues=sponsorship%3D'+commercial_video['package'];a+=c}e.setAttribute('vdb_params',a)}i(e.vdb_Player)}else{var t=arguments.callee;setTimeout(function(){t(e,i)},0)}}(document.getElementById('vidible_1'),onPlayerReadyVidible); Johnson & Johnson is seizing upon a U.S. Supreme Court ruling from Monday limiting where injury lawsuits can be filed to fight off claims it failed to warn women that talcum powder could cause ovarian cancer. New Jersey-based J&J has been battling a series of lawsuits over its talc-based products, including Johnson’s Baby Powder, brought by around 5,950 women and their families. The company denies any link between talc and cancer. A fifth of the plaintiffs have cases pending in state court in St. Louis, where juries in four trials have hit J&J and a talc supplier with $307 million in verdicts. Those four cases and most of the others on the St. Louis docket involve out-of-state plaintiffs suing an out-of-state company. On Monday, the Supreme Court ruled 8-1 in a case involving Bristol-Myers Squibb Co that state courts cannot hear claims against companies that are not based in the state when the alleged injuries did not occur there. The ruling immediately led a St. Louis judge at J&J’s urging to declare a mistrial in the latest talc case, in which two of the three women at issue were from out of state. It also could imperil prior verdicts and cases that have yet to go to trial. “We believe the recent U.S. Supreme Court ruling on the Bristol-Myers Squibb matter requires reversal of the talc cases that are currently under appeal in St. Louis,” J&J said in a statement. The question of where such lawsuits can be filed has been the subject of fierce debate. The business community has argued plaintiffs should not be allowed to shop around for the most favorable court to bring lawsuits, while injured parties claim corporations are trying to deny them access to justice. Along with talc cases, large-scale litigation alleging injuries from Bayer AG’s Essure birth control device in Missouri and California and GlaxoSmithKline’s antidepressant Paxil in California and Illinois are examples of other cases where defendants could utilize the Supreme Court decision. Although he declared a mistrial on Monday, St. Louis Circuit Judge Rex Burlison left the door open for the plaintiffs to argue they still have jurisdiction. Plaintiffs lawyer Ted Meadows said he would argue the St. Louis court still had jurisdiction based on a Missouri-based bottler J&J used to package its talc products, which he said would create a sufficient connection to the state. “It’s very disappointing to mistry a case because the Supreme Court changed the rules on us,” said Meadows. The lawsuit decided by the high court on Monday involved claims against Bristol-Myers and California-based drug distributor McKesson Corp by 86 California residents and 575 non-Californians over the blood thinner Plavix. Beyond Monday’s mistrial, the Supreme Court’s ruling could bolster a pending appeal by J&J of a $72 million verdict in favor of the family of Alabama resident Jacqueline Fox, who died in 2015. A Missouri appeals court had said in May it would wait until the Supreme Court issued its decision to decide the appeal. J&J has won only one of the five trials so far in Missouri. It previously sought to move talc cases out of St. Louis, but the Missouri Supreme Court in January denied its bid. The company has also cast the St. Louis court as overly plaintiff-friendly and has allowed evidence linking talc to cancer that was rejected by a New Jersey state court judge overseeing over 200 talc cases. The plaintiffs are appealing. The talc verdicts against J&J led the business-friendly American Tort Reform Association last year to declare the St. Louis state court the nation’s top “Judicial Hellhole.” Now J&J could try to use the Supreme Court ruling to dismiss many of the cases it faces in Missouri, according to legal experts. Corporations facing a large volume of cases in venues chosen by plaintiffs will likely cite the Supreme Court to try to dismiss those claims, said Rusty Perdew, a defense lawyer at the law firm Locke Lord. “You have a bunch of defendants who can go back and say, ‘Judge, you got that wrong and you’re going to have to dismiss claims by all those plaintiffs,’” he said. (This story was corrected to show that Perdew was speaking about corporations in general, not J&J, in next-to-last paragraph.)   (Reporting by Nate Raymond in Boston; Editing by Tom Brown and Bill Trott) -- This feed and its contents are the property of The Huffington Post, and use is subject to our terms. It may be used for personal consumption, but may not be distributed on a website.

Выбор редакции
19 июня, 17:34

Supreme Court ruling in drug case could have big implications for product liability

Bristol-Myers Squibb prevailed in its effort to get the Supreme Court to limit where patients can sue to seek compensation for harm caused by drugs.Justices Monday ruled, 8-1, for the drug company in a case that pitted BMS against the state of California and that could have broad implications for where manufacturers can be sued.The case centered around whether plaintiffs residing outside of California who claim they were harmed by BMS' blood thinner Plavix could join in a lawsuit brought by California residents against the New York-based company in California. The out-of-state residents didn't buy the drug or take it in California, and the product wasn't manufactured in the state."The mere fact that other plaintiffs were prescribed, obtained, and ingested Plavix in California — and allegedly sustained the same injuries as did the non-residents — does not allow the State to assert specific jurisdiction over the nonresidents' claims," wrote Justice Samuel Alito in the court's opinion.BMS and the government said California’s Supreme Court erred when it agreed that the out-of-state plaintiffs had standing in the case. The company argued failure to overturn the ruling would create more unpredictable conditions for corporations.A BMS win could limit patients' ability to “forum shop” cases against drugmakers. California is thought to be a particularly friendly state for injured plaintiffs, and a court victory for BMS could discourage patients from seeking relief there to boost their odds of a victory.

19 июня, 11:01

Why Is McKesson (MCK) Up 13% Since the Last Earnings Report?

McKesson (MCK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.